U-Chart Analysis:WAKAMOTO PHARMACEUTICAL CO.,LTD.:4512

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index WAKAMOTO PHARMACEUTICAL CO.,LTD. Go to web site 4512 Medicals 東証スタンダード March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 3,879 3,232 2,844 2,884 3,262
Other Current AssetsHelp 5,474 5,376 4,794 5,764 6,363
Tangible Fixed AssetsHelp 3,032 3,297 3,527 3,648 3,907
Intangible Fixed AssetHelp 202 196 201 485 472
Investments and OthersHelp 3,124 2,852 3,207 3,202 3,760
Total AssetsHelp 15,712 14,953 14,572 15,983 17,764
Total Current LiabilitiesHelp 3,804 3,471 3,184 4,033 4,001
Total Long-term LiabilitiesHelp 1 2 3 4 2
Shareholder's EquityHelp 11,907 11,481 11,386 11,947 13,761
Total LiabilitiesHelp 15,712 14,953 14,572 15,983 17,764

WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 8,660 8,383 8,896 10,917 10,740
Total Sales 8,660 8,383 8,896 10,917 10,740
Cost of SalesHelp 4,552 4,027 4,407 4,724 4,623
Other Costs and RevenueHelp 3,970 4,117 5,091 7,849 6,298
Total CostsHelp 8,522 8,145 9,498 12,573 10,921
Net RevenueHelp 4,108 4,356 4,489 6,193 6,117
Earnings Before TaxHelp 212 285 -703 -911 -230
Net IncomeHelp 138 239 -602 -1,657 -181
Net Income 138 239 -602 -1,657 -181

WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 632 339 163 -155 -114
Investing Cash Flow(ICF)Help 17 51 -200 -179 -205
Financing Cash FlowHelp -2 -2 -4 -44 -267
Exchange Difference of Cash and Cash EquivalentsHelp 0 -0 0 -0 0
Net Increase and Decrease in Cash and Cash Equivalentsn 647 388 -40 -378 -587

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

WAKAMOTO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

CHUGAI PHARMACEUTICAL CO., LTD.
Eisai Co.,Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
NANO MRNA Co., Ltd.
Mochida Pharmaceutical Co.,Ltd.
Cuorips Inc.
KYORIN Pharmaceutical Co., Ltd.
Sumitomo Pharma Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd.
MIKASA SEIYAKU CO.,LTD.